Division of Endocrinology, Boston Children's Hospital, Boston, Massachusetts, USA,
Department of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Horm Res Paediatr. 2019;92(4):276-283. doi: 10.1159/000502843. Epub 2019 Sep 18.
Minocycline, a member of the tetracycline class of antibiotics, has been associated with benign thyroid pigmentation but reports of thyroid dysfunction are sparse.
Cases were selected via an inquiry of the electronic medical records for patients with thyroid dysfunction and the use of a tetracycline antibiotic. Non-autoimmune thyroiditis was defined as abnormally low or suppressed thyroid-stimulating hormone (TSH, <0.3 µIU/mL), elevated free thyroxine or total thyroxine, and undetectable antithyroid antibodies.
Nine cases of thyroiditis without autoimmunity were identified out of 423 reviewed patients. Cases of thyroiditis occurred in adolescents ages 14-17 years who had been taking minocycline for 6 months to 4 years. In all cases, minocycline was prescribed for the treatment of acne. Four of the 9 received treatment for thyrotoxicosis with a β-blocker (in 3 cases) and/or antithyroid drug (in 2 cases). Thyroiditis was symptomatic in all but one individual who presented with painless goiter. All thyroiditis was transient and resolved after a median of 4.5 months (range 2-5 months). In one case, thyroiditis was followed by transient hypothyroidism.
Minocycline is known to cause thyroid abnormalities, although it has not been definitively linked to thyroid dysfunction. Here, we report 9 cases of non-autoimmune thyroiditis in adolescents receiving minocycline for acne. We recommend that minocycline exposure be considered in the differential diagnosis for thyroiditis and that patients receiving minocycline be counseled regarding the risk of thyroid dysfunction.
米诺环素是四环素类抗生素的一种,与良性甲状腺色素沉着有关,但甲状腺功能障碍的报道很少。
通过查询电子病历中甲状腺功能障碍和使用四环素抗生素的患者,选择病例。非自身免疫性甲状腺炎定义为异常低或抑制的促甲状腺激素(TSH,<0.3µIU/mL)、游离甲状腺素或总甲状腺素升高以及抗甲状腺抗体不可检测。
在 423 名接受审查的患者中,发现了 9 例无自身免疫性的甲状腺炎病例。甲状腺炎发生在 14-17 岁的青少年中,他们服用米诺环素 6 个月至 4 年。在所有病例中,米诺环素都被用于治疗痤疮。9 例中有 4 例因甲状腺毒症接受了β受体阻滞剂(3 例)和/或抗甲状腺药物(2 例)治疗。除了 1 例表现为无痛性甲状腺肿的个体外,所有甲状腺炎均有症状。所有甲状腺炎均为一过性,中位数为 4.5 个月(2-5 个月)后缓解。在 1 例中,甲状腺炎后出现短暂性甲状腺功能减退。
米诺环素已知会引起甲状腺异常,尽管尚未明确与甲状腺功能障碍有关。在这里,我们报告了 9 例青少年在接受米诺环素治疗痤疮时发生的非自身免疫性甲状腺炎。我们建议在鉴别诊断甲状腺炎时考虑米诺环素暴露,并告知接受米诺环素治疗的患者发生甲状腺功能障碍的风险。